REVIEW
Published on 03 Apr 2020
GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials
doi 10.3389/fendo.2020.00178
- 68,392 views
- 217 citations
- Frontiers in Endocrinology
- Molecular and Structural Endocrinology
- Research Topics
- GLP-1 analogues and DPP-4 inhibitors in type 2 diabetes therapy: from structural biology to clinics
GLP-1 analogues and DPP-4 inhibitors in type 2 diabetes therapy: from structural biology to clinics
69k
Total downloads
326k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 08 Nov 2019
Insights Into GLP-1 and GIP Actions Emerging From Vildagliptin Mechanism Studies in Man
doi 10.3389/fendo.2019.00780
- 3,143 views
- 5 citations
REVIEW
Published on 19 Jun 2019
Clinical Use of DPP-4 Inhibitors
doi 10.3389/fendo.2019.00389
- 62,668 views
- 248 citations
REVIEW
Published on 19 Jun 2019
DPP-4 Inhibition and the Path to Clinical Proof
doi 10.3389/fendo.2019.00376
- 16,073 views
- 74 citations
CORRECTION
Published on 03 May 2019
Corrigendum: Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
doi 10.3389/fendo.2019.00275
- 1,541 views
- 9 citations
REVIEW
Published on 26 Apr 2019
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
doi 10.3389/fendo.2019.00260
- 18,180 views
- 91 citations
REVIEW
Published on 12 Apr 2019
The Discovery and Development of Liraglutide and Semaglutide
doi 10.3389/fendo.2019.00155
- 167,081 views
- 545 citations
REVIEW
Published on 15 Feb 2019
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
doi 10.3389/fendo.2019.00080
- 62,927 views
- 299 citations
Published in
Frontiers in Endocrinology
- Molecular and Structural Endocrinology
Impact
- 326kTopic views
- 254kArticle views
- 69kArticle downloads